PhD in Synthetic Organic Chemistry-Trinity College Dublin (2017): Developing a novel synthetic methodology for the preparation of glycopeptides as therapeutics

Applications are invited for a PhD scholarship in Synthetic Organic Chemistry. Commencing in September 2017, the project will involve the development of a novel synthetic methodology for the preparation of glycopeptides as therapeutics. The successful candidate will receive training in methodology development, multi-step synthesis, thiol-ene ligation, peptide synthesis and carbohydrate chemistry.

Funding for the scholarship is a result of the award of a highly competitive Science Foundation Ireland CDA award to Prof. Eoin Scanlan.

Applications are welcome from students from Ireland/EU with, or expecting to gain, a first or upper second class honours degree (or equivalent). Experience in any area of modern chemical synthesis including organic methodology, natural product and target molecule synthesis, asymmetric synthesis, peptide or carbohydrate chemistry would be an advantage.

The successful candidate will join an exciting and dynamic research team and will be encouraged to develop their chemical knowledge, technical skills and transferable skills. They will attend courses on the Dublin Chemistry programme and attend group meetings, seminars and international conferences. They will develop advanced synthetic chemistry skills and gain particular expertise in synthetic methodology and peptide synthesis and ligation.

On graduation they should be well placed to pursue a career in either the pharmaceutical industry or as an academic researcher. Up to 4 years of scholarship for maintenance and fees is available for EU applicants thanks to generous funding by Science Foundation Ireland

The PhD will be supervised by Prof. Eoin Scanlan who is a PI in the School of Chemistry, Trinity College Dublin, and will be based in state-of-the-art research labs in the Trinity Biomedical Sciences Institute. The PI has a very strong track record and international reputation in developing novel synthetic methodologies and bioconjugates with publications in the leading chemistry journals.